TLDR
- Loop Capital initiated coverage on Astera Labs with a Buy rating and a $250 price target, implying around 110% upside from its prior close.
- The firm called ALAB the clearest “pure play” AI silicon stock outside of Nvidia.
- Astera Labs beat Q4 estimates with EPS of $0.58 vs. $0.51 expected, and revenue of $270.6M — up 91.8% year-over-year.
- Insiders sold 216,792 shares worth $26.8M in the last 90 days, though insiders still hold 12.5% of the stock.
- Loop Capital highlighted ALAB’s COSMOS software platform as a potential industry standard with “moat-like stickiness.”
Astera Labs picked up a new bull on Thursday when Loop Capital initiated coverage with a Buy rating and a $250 price target.
Astera Labs, Inc. Common Stock, ALAB
That target implies roughly 110% upside from the stock’s prior close. ALAB opened at $119.00 on Thursday, well below its 1-year high of $262.90.
Analyst Ananda Baruah called Astera Labs the company “most representing a diversified AI silicon pure play” outside of Nvidia.
The thesis is straightforward: as AI infrastructure gets bigger and more complex, the connectivity solutions ALAB makes become harder to replace.
Loop Capital noted that ALAB has exposure across “essentially all Gen AI silicon flavors” — GPUs, Trainium, TPUs, and other accelerators. That breadth is rare among semiconductor names.
The firm also pointed to Astera Labs’ COSMOS software and management platform as a potential long-term edge. Baruah wrote that it “could become industry standard,” creating what he described as “moat-like stickiness” with customers.
Strong Recent Earnings
The initiation comes on the back of a solid Q4 report. Astera Labs posted EPS of $0.58 for the quarter, beating the $0.51 consensus estimate by $0.07.
Revenue came in at $270.6M, topping the $249.5M estimate and rising 91.8% from the same period last year.
The company set Q1 2026 EPS guidance at $0.530–$0.540. Analysts on average expect full-year EPS of $0.34.
Insider Selling Worth Watching
Not everything is pointing in one direction. Insiders have been active sellers over the past 90 days.
General Counsel Philip Mazzara sold 10,000 shares on March 2nd at an average of $117.47, a 7.24% reduction in his position.
COO Sanjay Gajendra sold 94,971 shares on February 17th at an average of $123.81, trimming his stake by 5.84%.
In total, insiders sold 216,792 shares worth approximately $26.8M over the last 90 days. Insiders still own 12.5% of the company.
On the analyst side, the picture is mixed but leans positive. Of 22 analysts tracked by MarketBeat, 15 have Buy ratings, six have Hold ratings, and one has a Sell.
The average price target sits at $195.89. Barclays has the lowest target on the Street at $165.00, set in January.
The stock trades at a P/E of 97.54 with a market cap of $20.26 billion. Its 50-day moving average is $154.84, and the 200-day sits at $170.88 — both well above the current price.
Astera Labs has a 1-year low of $47.13.





